The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples